4.8 Article

NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration

期刊

NATURE
卷 452, 期 7189, 页码 887-U8

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nature06721

关键词

-

资金

  1. Howard Hughes Medical Institute Funding Source: Medline
  2. NICHD NIH HHS [P30 HD024064-20, P30 HD024064] Funding Source: Medline

向作者/读者索取更多资源

Neurodegeneration can be triggered by genetic or environmental factors. Although the precise cause is often unknown, many neurodegenerative diseases share common features such as protein aggregation and age dependence. Recent studies in Drosophila have uncovered protective effects of NAD synthase nicotinamide mononucleotide adenylyltransferase ( NMNAT) against activity-induced neurodegeneration and injury- induced axonal degeneration(1,2). Here we show that NMNAT overexpression can also protect against spinocerebellar ataxia 1 ( SCA1)- induced neurodegeneration, suggesting a general neuroprotective function of NMNAT. It protects against neurodegeneration partly through a proteasome-mediated pathway in a manner similar to heat- shock protein 70 ( Hsp70). NMNAT displays chaperone function both in biochemical assays and cultured cells, and it shares significant structural similarity with known chaperones. Furthermore, it is upregulated in the brain upon overexpression of poly- glutamine expanded protein and recruited with the chaperone Hsp70 into protein aggregates. Our results implicate NMNAT as a stress- response protein that acts as a chaperone for neuronal maintenance and protection. Our studies provide an entry point for understanding how normal neurons maintain activity, and offer clues for the common mechanisms underlying different neurodegenerative conditions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据